Deepfakes in a Doctor’s Coat: Delhi High Court Permanently Protects Dr. Devi Prasad Shetty’s Personality Rights

November 16, 2026
Deepfakes in a Doctor’s Coat

By Vikrant Rana and Huda Jafri

The Delhi High Court has granted permanent protection against the unauthorised use of renowned cardiac surgeon Dr. Devi Prasad Shetty’s identity in AI-generated videos promoting purported medical cures. In Dr. Devi Prasad Shetty & Anr. v. Medicine Me & Ors.,[1] decided on 5 October 2026, Justice Purushaindra Kumar Kaurav reaffirmed that personality rights extend to a person’s name, image, voice and likeness, including against misuse through artificial intelligence and deepfake technology. The Court also permanently restrained the infringement of registered trademarks belonging to Narayana Hrudayalaya Ltd., the hospital group of which Dr. Shetty is the founding chairman.

The judgment, reported as 2026:DHC:8897, is significant not merely for its protection of personality and trademark rights, but also for its recognition that fabricated medical endorsements can pose a direct risk to public health.

Background: Fabricated Medical Endorsements on Social Media

The suit was brought by Dr. Devi Prasad Shetty, a Padma Bhushan awardee and renowned cardiac surgeon with over four decades of experience, and Narayana Hrudayalaya Ltd., the Bengaluru-based hospital group of which he is the founding chairman.

Narayana Hrudayalaya owns registered trademarks including NARAYANA HRUDAYALAYA, NARAYANA HEALTH and the “N-1” device marks. The plaintiffs approached the Court alleging that their rights were being infringed through fabricated audio-visual content circulated on Facebook and YouTube.

The content defendants included three Facebook pages, five YouTube channels and unidentified persons arrayed as a John Doe defendant. The videos allegedly exploited Dr. Shetty’s name, image, voice and likeness, including through AI tools and deepfake technology, to lend credibility to false medical claims.

The impugned videos included:

  • A video styled as a news telecast, falsely depicting Dr. Shetty as promoting a drug claimed to cure Type II diabetes.
  • A video depicting him as having formulated a drug for high blood pressure.
  • A video showing him promoting an alternative treatment for hypertension, which also displayed Narayana Hrudayalaya’s registered “N-1” device mark.
  • Videos in Hindi and Bengali presenting health advice in his name, in some instances by voicing over clips taken from his earlier public interviews.

The misuse had consequences beyond reputational harm. A member of the public wrote to the Chief Marketing Officer of Narayana Hrudayalaya enquiring whether the hypertension video was authentic and expressing an interest in trying the medication on the belief that it was backed by a renowned doctor.

Meta Platforms Inc. and Google LLC, the platforms on which the content was hosted, were impleaded as defendants. The Department of Telecommunications (DoT) and the Ministry of Electronics and Information Technology (MeitY) were also joined to facilitate the implementation of blocking directions.

The Registered Trademarks

Narayana Hrudayalaya Ltd. is the registered proprietor of several word and device marks. The marks reproduced in the judgment are set out below.

amendments within 15 days
Registered mark Description Relevance in the case
NARAYANA HRUDAYALAYA NARAYANA HRUDAYALAYA (word mark) House mark adopted on incorporation in 2000; covered by the injunction
“N-1” device mark with NARAYANA HEALTH “N-1” device mark with NARAYANA HEALTH “N-1” device marks were displayed in one Facebook video and one YouTube video
“N-1” (NH) device mark “N-1” (NH) device mark As above
NARAYANA HEALTH logo NARAYANA HEALTH logo NARAYANA HEALTH adopted in April 2001; “Narayana Health” was used as a hashtag by a YouTube channel

Source: Delhi High Court, 2026:DHC:8897.

Decree Without Trial:

None of the content defendants filed a written statement, and their right to do so stood closed, while the platforms had complied with the interim directions issued on 28 November 2024. The Court therefore considered whether the suit could be decreed under Order VIII Rule 10 of the Code of Civil Procedure (CPC) without requiring a trial or further evidence.

The Court examined the principles laid down by the Supreme Court in C.N. Ramappa Gowda,[2] read alongside Nirog Pharma[3] and Satya Infrastructure.[4] It held that these authorities were consistent rather than conflicting.

The caution against mechanically decreeing a suit merely because the defendant has failed to file a written statement is directed at a plaint that itself throws up two versions of the facts. It does not prevent a court from granting a decree where the pleadings and supporting documents are unimpeachable and the defendants, despite having suffered an injunction, have put forward no version at all.

Applying this principle, the Court found that the plaint was duly verified, supported by affidavits and accompanied by the impugned videos in electronic form. The material was, by and large, self-speaking: the videos did not originate from Dr. Shetty, attributed to him statements he had never made, and used his name and likeness, and in certain instances Narayana Hrudayalaya’s registered marks, to lend credibility to purported medicines and medical advice.

In the absence of any written statement or affidavit of admission and denial, the averments in the plaint were taken as admitted. The Court concluded that no disputed question of fact required a trial.

The Court’s Findings

  1. Personality Rights: Protection Against AI and Deepfake Misuse
    Relying on Anil Kapoor v. Simply Life India,[5] the Court reaffirmed that the personality and publicity rights of a well-known individual, comprising their name, image, voice, likeness and other indicia of persona, have consistently been recognised and protected, particularly against misuse through artificial intelligence and deepfake technology.

    In the present case, Dr. Shetty was clearly identifiable in the impugned content, which attributed to him statements he never made in order to lend an appearance of legitimacy to medical claims. The Court accordingly granted a permanent injunction against the unauthorised exploitation of his persona.

  2. Public Health: More Than a Question of Reputation
    A particularly important aspect of the judgment is the Court’s emphasis on the consequences for public health.

    The Court observed that the misuse was not confined to the commercial appropriation of a well-known person’s identity. The fabricated videos attributed to a cardiac surgeon claims of cures for diabetes, hypertension and other cardiac ailments that he never made.

    The email received by Narayana Hrudayalaya demonstrated that such content could influence real-world decisions. The Court therefore recognised that the harm did not stop at Dr. Shetty’s reputation but extended to members of the public who may act upon such content.

    This aspect of the ruling is especially relevant to healthcare providers, pharmaceutical companies and medical professionals whose reputations may be exploited to promote unverified or potentially harmful treatments.

  3. Trademark Infringement: Unauthorised Use of Narayana Hrudayalaya’s Marks
    The Court found that the use of Narayana Hrudayalaya’s registered marks, including the “N-1” device mark and “Narayana Health”, without any licence or authorisation, was evidently intended to suggest an association with the hospital group and its healthcare services. This amounted to infringement under Section 29 of the Trade Marks Act, 1999.

    In decreeing the suit, the Court drew support from Global Health v. Denish P Kalariya,[6] where a trademark infringement suit was decreed because the interim relief had been fully availed and the relief sought was unopposed, and from Rajat Sharma v. Tamara Doc,[7] which concerned deepfake videos of a well-known journalist and the INDIA TV trademarks and was decreed against non-contesting defendants.

The Decree: Permanent Injunctions and Platform Directions

The Court made the interim order of 28 November 2024 absolute and decreed the suit. The principal directions were as follows:

  • Permanent injunction: The content defendants and unidentified persons were permanently restrained, in terms of the relevant prayers in the plaint, from exploiting Dr. Shetty’s personality and publicity rights and from infringing Narayana Hrudayalaya Ltd.’s registered trademarks.
  • Takedown and blocking: The interim directions requiring Meta and Google to take down the impugned content and disclose available details of the uploaders, in accordance with law, were made absolute. The directions to the DoT and MeitY to issue blocking directions to telecom and internet service providers were also made absolute.
  • Procedure for future infringing content: The plaintiffs were granted liberty to notify Meta and Google, copying their counsel, of subsequently discovered infringing URLs or content, with supporting particulars on an affidavit. The platforms must independently examine such requests and act under their respective policies. If the platforms do not act, the plaintiffs may approach the Court for appropriate directions.
  • Well-known trademark status: The prayer for a declaration that the marks are well-known under Section 2(1)(zg) of the Trade Marks Act, 1999 was not decided and the plaintiffs’ rights on it were reserved, as the examination of the factors under Section 11(6) had not been undertaken in these proceedings.
  • Damages and costs: The plaintiffs did not press their claims for damages and costs, which were dismissed as not pressed.

Conclusion

The Delhi High Court’s decision in Dr. Devi Prasad Shetty & Anr. v. Medicine Me & Ors. reinforces the legal protection available against the unauthorised use of a person’s identity through AI-generated content and deepfakes. It also highlights the additional concerns that arise when fabricated videos exploit a medical professional’s credibility to promote purported cures.

The ruling’s significance lies in the intersection of personality rights, trademark protection and public health. By granting a permanent injunction and confirming the takedown and blocking directions, the Court made clear that the misuse of a doctor’s identity to lend credibility to false medical claims can warrant lasting judicial intervention.

For hospitals, healthcare companies and medical professionals, the decision offers a useful reminder that an effective response to medical deepfakes may require coordinated action to protect personal identity, brand reputation and the public from misleading health claims.

Aysha Sasmin, Intern at S.S. Rana & Co. has assisted in the research of this article.

[1] Dr. Devi Prasad Shetty & Anr. v. Medicine Me & Ors., CS(COMM) 1053/2024, High Court of Delhi, judgment dated 05.10.2026, 2026:DHC:8897.

[2] C.N. Ramappa Gowda v. C.C. Chandregowda, (2012) 5 SCC 265.

[3] Nirog Pharma Pvt. Ltd. v. Umesh Gupta, (2016) 235 DLT 354.

[4] Satya Infrastructure Ltd. v. Satya Infra & Estates Pvt. Ltd., 2013 SCC OnLine Del 508.

[5] Anil Kapoor v. Simply Life India & Ors., CS(COMM) 652/2023, order dated 30.04.2024.

[6] Global Health Limited & Anr. v. Mr. Denish P Kalariya & Ors., 2026:DHC:8427.

[7] Rajat Sharma & Anr. v. Tamara Doc & Ors., CS(COMM) 1147/2024, order dated 24.08.2026.

For more information please contact us at : info@ssrana.com